EN
HI
Beta Drugs Share price
2559
109.30 (-4.10%)Last updated on 12 Aug, 2026 | 15:56 IST
Beta Drugs share price chart
Beta Drugs Share Key Metrics
Volume
1.11 L
Market Cap
2594.03 CR
LTQ@LTP
10@2559.00
ATP
2667.15
Var Margin
23.98 %
Circuit Range
2134.7-3201.9
Delivery %
49.41 %
Value
29.58 CR
ASM/GSM
No
Market Lot
1
Summary
BETA stock price is ₹2559 as of 12 Aug, 2026. The stock intraday movement has stayed between ₹2544.10 and ₹2807.90, while Beta Drugs share price 52 week high low is ₹990.10 & ₹2807.90.
In terms of trading activity, BETA share price has recorded a volume of 1,10,912 shares. The Beta Drugs has a market cap of ₹10136890. The stock’s Average Traded Price (ATP) stands at ₹2667.15, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹2559.00.
The Beta Drugs upper circuit limit is ₹3201.90 & The Beta Drugs lower circuit limit is ₹2134.70, with a Value of ₹29.58 CR. The Delivery Percentage for the day is 49.41%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Beta Drugs Resistance and Support
Pivot 2616.77
Resistance
First Resistance
2763.54
Second Resistance
2858.77
Third Resistance
3005.54
Support
First Support
2521.54
Second Support
2374.77
Third Support
2279.54
Beta Drugs Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
59.1%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
1.02%
Domestic Institutional Investors
6.22%
Retail
33.66%
Others
0%
Total Promoters
MAR '26
64.63%
JUN '26
59.1%
Beta Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-20 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2026-01-09 | Others |
Beta Drugs Management
| Name | Position |
|---|---|
| Rahul Batra | Chairman & Managing Director |
| Varun Batra | Joint Managing Director |
Beta Drugs Similar Stocks
SMS Pharmaceuticals Ltd.
369.55
-9.20 (2.43%)
Advanced Enzyme Technologies Ltd.
301.65
3.35 (1.12%)
Kwality Pharmaceuticals Ltd.
3313.80
3.30 (0.10%)
Dishman Carbogen Amcis Ltd.
191.15
-2.28 (1.18%)
Hikal Ltd.
212.84
-5.14 (2.36%)
Sai Parenteral's Ltd.
552.40
-21.10 (3.68%)
Solara Active Pharma Sciences Ltd.
505.60
-3.10 (0.61%)
Panacea Biotec Ltd.
399.85
-2.35 (0.58%)
Dr Agarwals Eye Hospital Ltd.
5311.50
-3.00 (0.06%)
Beta Drugs FAQs
The Buying Price of Beta Drugs share is 2559 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Beta Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beta Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Beta Drugs shares is 71.31. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Beta Drugs shares is 11.28. Useful to assess the stock's value relative to its book value.
To assess Beta Drugs’s valuation compare Sector P/E, P/B which are 65.02 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Beta Drugs is 2594.03 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Beta Drugs share price is 2807.90 & 990.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Beta Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in BETA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC